Biotechnology - Licensing

Filter

Current filters:

Licensing

Popular Filters

1 to 25 of 416 results

AstraZeneca inks deal with Orca for autoimmune disease drugs

AstraZeneca inks deal with Orca for autoimmune disease drugs

25-02-2015

Anglo-Swedish pharma major AstraZeneca and Orca Pharmaceuticals, a UK based biopharmaceutical company,…

AstraZenecaBiotechnologyImmunologicalsInflammatory diseasesLicensingOrca PharmaceuticalsRespiratory and PulmonaryUK

Genmab inks DuoBody deal with BioNovion in the field of immuno-oncology

19-02-2015

Danish biotech company Genmab has entered into a co-development and commercialization agreement with…

BioNovionBiotechnologyDuoBodyGenmabImmunologicalsLicensingOncologyResearch

Ono signs deal with Dako for Opdivo companion diagnostic test

Ono signs deal with Dako for Opdivo companion diagnostic test

16-02-2015

Japanese pharma company Ono Pharmaceutical and Danish diagnostic provider Dako have signed a new partnership…

BiotechnologyDakoJapanLicensingOncologyOno PharmaceuticalOpdivo

TiGenix and Lonza sign agreement for the manufacture of Crohn’s disease treatment

TiGenix and Lonza sign agreement for the manufacture of Crohn’s disease treatment

12-02-2015

Swiss CMO Lonza and Belgian cell therapy firm TiGenix have agreed that Lonza will manufacture material…

BiotechnologyGastro-intestinalsLicensingLonzaTiGenixUSA

Voyager inks up to $845 million deal with Genzyme on novel CNS products

Voyager inks up to $845 million deal with Genzyme on novel CNS products

12-02-2015

US gene therapy start-up company Voyager Therapeutics has entered into a major strategic collaboration…

BiotechnologyGenzymeLicensingNeurologicalResearchSanofiUSAVoyager Therapeutics

Pfenex soars on Lucentis biosimilar deal with Hospira

Pfenex soars on Lucentis biosimilar deal with Hospira

10-02-2015

Shares of US clinical-stage biotech firm Pfenex leapt 28% to $8.85 in morning trading, after the company…

BiosimilarsBiotechnologyGenentechGlobalHospiraLicensingLucentisNovartisOphthalmicsPF582PfenexResearchRoche

Pfizer abandons deal with Repligen on SMA drug candidate

Pfizer abandons deal with Repligen on SMA drug candidate

03-02-2015

US biologics specialist Repligen revealed in a filing with the Securities and Exchange Commission that…

BiotechnologyLicensingNeurologicalPfizerRepligenRG3039

NicOx in-licenses AzaSite and BromSite from InSite Vision

NicOx in-licenses AzaSite and BromSite from InSite Vision

02-02-2015

Ophthalmology-focused French biotech firm NicOx has signed a license agreement with USA-based InSite…

AzaSiteBiotechnologyBromSiteEuropeInSite VisionLicensingNicOxOphthalmicsRest of the World

CMOs must offer meaningful value to take advantage of biosimilars trend, says report

30-01-2015

If contract manufacturing organizations are to take advantage of the wave of interest in biosimilars,…

BiosimilarsBiotechnologyComputer hardwareLicensingPharmSourceProduction

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

29-01-2015

France-based biotech firm Valneva and UK company Immune Targeting Systems (ITS) have signed an exclusive…

Anti-viralsBiotechnologyGlobalImmune Targeting SystemsLicensingValneva

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

29-01-2015

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT…

BiotechnologyG-treeBNTLicensingMergers & AcquisitionsOphthalmicsRegeneRxRGN-259USA

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

Gilead expands hepatitis C agreements to include sofosbuvir/GS-5816 single tablet regimen

26-01-2015

US biotech major Gilead Sciences has expanded its hepatitis C generic licensing agreements to include…

Anti-viralsBiotechnologyGenericsGilead SciencesIndiaLicensingSovaldiUSA

Solasia Pharma and Meiji Seika Pharma collaborate on darinaparsin

19-01-2015

Privately-held Solasia Pharma and fellow Japanese drugmaker Meiji Seika Pharma have entered into a license…

BiotechnologydarinaparsinJapanLicensingMeiji Seika PharmaOncologyResearchSolasia PharmaZiopharm Oncology

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

C4X Discovery enters into new research agreement with Evotec AG for treating addiction

19-01-2015

UK-based C4X Discovery Holdings has entered into a research agreement with drug discovery alliance Evotec.

BiotechnologyC4X DiscoveryEvotec AGLicensingNeurologicalUK

Cellectis links with Ohio State University on multiple myeloma technology

16-01-2015

France-based genome engineering specialist Cellectis has entered into an exclusive license agreement…

BiotechnologyCD123CD38CellectisCS1LicensingOncologyResearch

AstraZeneca unit in deal with Omnis Pharma for oncolytic viruses in immuno-oncology

15-01-2015

Anglo-Swedish pharma major AstraZeneca’s biologics R&D subsidiary MedImmune has entered into a licensing…

AstraZenecaBiotechnologyLicensingMedImmuneOmnis PharmaceuticalsOncology

Treeway collaborates with uniQure on gene therapy for ALS

15-01-2015

Netherlands-based biotech firm Treeway has entered into a collaboration with Dutch gene therapy company…

BiotechnologyLicensingNeurologicalResearchTreewayuniQure

Celgene exercises option on Agios Pharma’ AG-120

Celgene exercises option on Agios Pharma’ AG-120

14-01-2015

US cancer metabolism specialist Agios Pharmaceuticals says that biotech major Celgene will exercise its…

AG-120Agios PharmaceuticalsBiotechnologyCelgene CorpLicensingOncologyUSA

Mersana Therapeutics in up to $300 million deal with Takeda

13-01-2015

Privately-held US biotech company Mersana Therapeutics has expanded its ongoing collaboration with Japan’s…

BiotechnologyLicensingMersana TherapeuticsOncologyTakeda Pharmaceutical

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

AC Immune out-licenses anti-Tau vaccine to Janssen in up to $509 million deal

12-01-2015

Switzerland’s biopharma company AC Immune has entered into a worldwide exclusive license agreement…

AC ImmuneBiotechnologyGlobalJanssen Research & DevelopmentJohnson & JohnsonLicensingNeurological

Egalet buys in two innovative approved pain products, Oxaydo and Sprix

09-01-2015

US biotech firm Egalet Corp has in-licensing two innovative approved pain products transforming Egalet…

Acura PharmaceuticalsBiotechnologyDaiichi SankyoEgalet CorpGlobalLicensingLuitpold PharmaNeurologicalOxaydoSPRIX

1 to 25 of 416 results

COMPANY SPOTLIGHT

Menarini

Back to top